Fysiobelgium: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Fysiobelgium
Largest movements
- Stocks and contracts +€3,943
new in 2025: €3,943
- Receivables within one year -€1,736
down €1,736 (-97.7%), from €1,778 to €42
of which Trade receivables: -€1,738
- Cash +€381
up €381 (+34.3%), from €1,111 to €1,492
mainly Other debts (+€6,078) and Receivables within one year (+€1,736)
- Tangible fixed assets -€165
down €165 (-21.4%), from €770 to €605
- Other debts +€6,078
up €6,078 (+214%), from €2,834 to €8,912
- Profit (loss) carried forward -€3,669
down €3,669 (-164%), from -€2,241 to -€5,909
- Gross operating margin -€2,059
down €2,059 (-162%), from -€1,269 to -€3,328
- Depreciation +€110
up €110 (+198%), from €55 to €165
- Financial charges +€55
new in 2025: €55
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,658 | €6,081 | +€2,423 | +66.2% |
| Fixed assets | 21/28 | €770 | €605 | -€165 | -21.4% |
| Tangible fixed assets | 22/27 | €770 | €605 | -€165 | -21.4% |
| Plant, machinery and equipment | 23 | €770 | €605 | -€165 | -21.4% |
| Current assets | 29/58 | €2,889 | €5,476 | +€2,588 | +89.6% |
| Stocks and contracts in progress | 3 | - | €3,943 | +€3,943 | |
| Stocks | 30/36 | - | €3,943 | +€3,943 | |
| Amounts receivable within one year | 40/41 | €1,778 | €42 | -€1,736 | -97.7% |
| Trade receivables | 40 | €1,738 | - | -€1,738 | |
| Other amounts receivable | 41 | €40 | €42 | +€2 | +5.1% |
| Cash at bank and in hand | 54/58 | €1,111 | €1,492 | +€381 | +34.3% |
| Total equity and liabilities | 10/49 | €3,658 | €6,081 | +€2,423 | +66.2% |
| Equity | 10/15 | €759 | -€2,909 | -€3,669 | |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€2,241 | -€5,909 | -€3,669 | -164% |
| Amounts payable | 17/49 | €2,899 | €8,990 | +€6,092 | +210% |
| Amounts payable within one year | 42/48 | €2,899 | €8,990 | +€6,092 | +210% |
| Trade debts | 44 | €65 | €79 | +€14 | +21.3% |
| Suppliers | 440/4 | €65 | €79 | +€14 | +21.3% |
| Other amounts payable | 47/48 | €2,834 | €8,912 | +€6,078 | +214% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €55 | €165 | +€110 | +198% |
| Other operating charges | 640/8 | €118 | €120 | +€2 | +1.7% |
| Gross operating margin | 9900 | -€1,269 | -€3,328 | -€2,059 | -162% |
| Operating profit (loss) | 9901 | -€1,443 | -€3,613 | -€2,171 | -150% |
| Financial charges | 65/66B | - | €55 | +€55 | |
| Recurring financial charges | 65 | - | €55 | +€55 | |
| Profit (loss) for the period before taxes | 9903 | -€1,443 | -€3,669 | -€2,226 | -154% |
| Profit (loss) for the period | 9904 | -€1,443 | -€3,669 | -€2,226 | -154% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,443 | -€3,669 | -€2,226 | -154% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.